RAB18 regulates extrahepatic siRNA-mediated gene silencing efficacy.
Saved in:
| Title: | RAB18 regulates extrahepatic siRNA-mediated gene silencing efficacy. |
|---|---|
| Authors: | Lu J; Precision Biology, Amgen Inc., South San Francisco, CA 94080, USA., Lee J; Precision Biology, Amgen Inc., South San Francisco, CA 94080, USA., Yuan E; Precision Biology, Amgen Inc., South San Francisco, CA 94080, USA., Wakefield DL; Precision Biology, Amgen Inc., South San Francisco, CA 94080, USA., Kanke M; Precision Biology, Amgen Inc., South San Francisco, CA 94080, USA., Pruitt D; Cardiometabolic Disorders, Amgen Inc., South San Francisco, CA 94080, USA., Barreda J; Cardiometabolic Disorders, Amgen Inc., South San Francisco, CA 94080, USA., Rulifson IC; Cardiometabolic Disorders, Amgen Inc., South San Francisco, CA 94080, USA., Xie J; Precision Biology, Amgen Inc., South San Francisco, CA 94080, USA., Ferbas J; Precision Biology, Amgen Inc., South San Francisco, CA 94080, USA., Long J; RNA Therapeutics, Amgen Inc., Thousand Oaks, CA 91320, USA., Meade B; RNA Therapeutics, Amgen Inc., Thousand Oaks, CA 91320, USA., Homann O; CRADI Computational Biology, Amgen Inc., South San Francisco, CA 94080, USA., Guo W; Cardiometabolic Disorders, Amgen Inc., South San Francisco, CA 94080, USA., Gomes T; Precision Biology, Amgen Inc., South San Francisco, CA 94080, USA., Zhou H; Precision Biology, Amgen Inc., South San Francisco, CA 94080, USA., Wu B; Therapeutic Discovery, Amgen Inc., Thousand Oaks, CA 91320, USA., Cui J; Cardiometabolic Disorders, Amgen Inc., South San Francisco, CA 94080, USA., Wang S; Precision Biology, Amgen Inc., South San Francisco, CA 94080, USA. |
| Source: | Molecular therapy. Nucleic acids [Mol Ther Nucleic Acids] 2024 Sep 10; Vol. 35 (4), pp. 102335. Date of Electronic Publication: 2024 Sep 10 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Cell Press Country of Publication: United States NLM ID: 101581621 Publication Model: eCollection Cited Medium: Print ISSN: 2162-2531 (Print) Linking ISSN: 21622531 NLM ISO Abbreviation: Mol Ther Nucleic Acids Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39380712 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: RAB18 regulates extrahepatic siRNA-mediated gene silencing efficacy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Lu+J%22">Lu J</searchLink>; Precision Biology, Amgen Inc., South San Francisco, CA 94080, USA.<br /><searchLink fieldCode="AU" term="%22Lee+J%22">Lee J</searchLink>; Precision Biology, Amgen Inc., South San Francisco, CA 94080, USA.<br /><searchLink fieldCode="AU" term="%22Yuan+E%22">Yuan E</searchLink>; Precision Biology, Amgen Inc., South San Francisco, CA 94080, USA.<br /><searchLink fieldCode="AU" term="%22Wakefield+DL%22">Wakefield DL</searchLink>; Precision Biology, Amgen Inc., South San Francisco, CA 94080, USA.<br /><searchLink fieldCode="AU" term="%22Kanke+M%22">Kanke M</searchLink>; Precision Biology, Amgen Inc., South San Francisco, CA 94080, USA.<br /><searchLink fieldCode="AU" term="%22Pruitt+D%22">Pruitt D</searchLink>; Cardiometabolic Disorders, Amgen Inc., South San Francisco, CA 94080, USA.<br /><searchLink fieldCode="AU" term="%22Barreda+J%22">Barreda J</searchLink>; Cardiometabolic Disorders, Amgen Inc., South San Francisco, CA 94080, USA.<br /><searchLink fieldCode="AU" term="%22Rulifson+IC%22">Rulifson IC</searchLink>; Cardiometabolic Disorders, Amgen Inc., South San Francisco, CA 94080, USA.<br /><searchLink fieldCode="AU" term="%22Xie+J%22">Xie J</searchLink>; Precision Biology, Amgen Inc., South San Francisco, CA 94080, USA.<br /><searchLink fieldCode="AU" term="%22Ferbas+J%22">Ferbas J</searchLink>; Precision Biology, Amgen Inc., South San Francisco, CA 94080, USA.<br /><searchLink fieldCode="AU" term="%22Long+J%22">Long J</searchLink>; RNA Therapeutics, Amgen Inc., Thousand Oaks, CA 91320, USA.<br /><searchLink fieldCode="AU" term="%22Meade+B%22">Meade B</searchLink>; RNA Therapeutics, Amgen Inc., Thousand Oaks, CA 91320, USA.<br /><searchLink fieldCode="AU" term="%22Homann+O%22">Homann O</searchLink>; CRADI Computational Biology, Amgen Inc., South San Francisco, CA 94080, USA.<br /><searchLink fieldCode="AU" term="%22Guo+W%22">Guo W</searchLink>; Cardiometabolic Disorders, Amgen Inc., South San Francisco, CA 94080, USA.<br /><searchLink fieldCode="AU" term="%22Gomes+T%22">Gomes T</searchLink>; Precision Biology, Amgen Inc., South San Francisco, CA 94080, USA.<br /><searchLink fieldCode="AU" term="%22Zhou+H%22">Zhou H</searchLink>; Precision Biology, Amgen Inc., South San Francisco, CA 94080, USA.<br /><searchLink fieldCode="AU" term="%22Wu+B%22">Wu B</searchLink>; Therapeutic Discovery, Amgen Inc., Thousand Oaks, CA 91320, USA.<br /><searchLink fieldCode="AU" term="%22Cui+J%22">Cui J</searchLink>; Cardiometabolic Disorders, Amgen Inc., South San Francisco, CA 94080, USA.<br /><searchLink fieldCode="AU" term="%22Wang+S%22">Wang S</searchLink>; Precision Biology, Amgen Inc., South San Francisco, CA 94080, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101581621%22">Molecular therapy. Nucleic acids</searchLink> [Mol Ther Nucleic Acids] 2024 Sep 10; Vol. 35 (4), pp. 102335. <i>Date of Electronic Publication: </i>2024 Sep 10 (<i>Print Publication: </i>2024). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101581621 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2162-2531 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221622531%22">21622531 </searchLink><i>NLM ISO Abbreviation: </i>Mol Ther Nucleic Acids <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39380712 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.omtn.2024.102335 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 102335 Titles: – TitleFull: RAB18 regulates extrahepatic siRNA-mediated gene silencing efficacy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lu J – PersonEntity: Name: NameFull: Lee J – PersonEntity: Name: NameFull: Yuan E – PersonEntity: Name: NameFull: Wakefield DL – PersonEntity: Name: NameFull: Kanke M – PersonEntity: Name: NameFull: Pruitt D – PersonEntity: Name: NameFull: Barreda J – PersonEntity: Name: NameFull: Rulifson IC – PersonEntity: Name: NameFull: Xie J – PersonEntity: Name: NameFull: Ferbas J – PersonEntity: Name: NameFull: Long J – PersonEntity: Name: NameFull: Meade B – PersonEntity: Name: NameFull: Homann O – PersonEntity: Name: NameFull: Guo W – PersonEntity: Name: NameFull: Gomes T – PersonEntity: Name: NameFull: Zhou H – PersonEntity: Name: NameFull: Wu B – PersonEntity: Name: NameFull: Cui J – PersonEntity: Name: NameFull: Wang S IsPartOfRelationships: – BibEntity: Dates: – D: 10 M: 09 Text: 2024 Sep 10 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 2162-2531 Numbering: – Type: volume Value: 35 – Type: issue Value: 4 Titles: – TitleFull: Molecular therapy. Nucleic acids Type: main |
| ResultId | 1 |